The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters

[1]  Randy D Blakely,et al.  Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Sutcliffe,et al.  Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. , 2005, American journal of human genetics.

[3]  Randy D Blakely,et al.  Biogenic amine neurotransmitter transporters: just when you thought you knew them. , 2005, Physiology.

[4]  A. Siegel,et al.  Potentiating role of interleukin-1β (IL-1β) and IL-1β type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat , 2005, Brain Research.

[5]  R. Blakely,et al.  p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process* , 2005, Journal of Biological Chemistry.

[6]  S. Koka,et al.  Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. , 2005, Biochemical and biophysical research communications.

[7]  R. Malenka,et al.  Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α , 2005, The Journal of Neuroscience.

[8]  Z. Karádi,et al.  Single neuron activity changes to interleukin-1β in the orbitofrontal cortex of the rat , 2005, Brain Research.

[9]  D. Mann,et al.  TNF-acts via p 38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1 / MAFbx in skeletal muscle , 2005 .

[10]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  J. Saklatvala The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. , 2004, Current opinion in pharmacology.

[12]  R. Blakely,et al.  Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. , 2004, Molecular pharmacology.

[13]  I. Sora,et al.  Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders , 2003, Genes, brain, and behavior.

[14]  B. Greenberg,et al.  Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype , 2003, Molecular Psychiatry.

[15]  O. Kaut,et al.  Constitutive expression of p55TNFR mRNA and mitogen‐specific up‐regulation of TNFα and p75TNFR mRNA in mouse brain , 2003, The Journal of comparative neurology.

[16]  M. Mariotti,et al.  Interleukin‐1β enhances non‐rapid eye movement sleep when microinjected into the dorsal raphe nucleus and inhibits serotonergic neurons in vitro , 2003, The European journal of neuroscience.

[17]  O. Çalıyurt,et al.  Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder , 2003, Psychopharmacology.

[18]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[19]  R. Blakely,et al.  Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the α2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304) , 2003, Journal of Pharmacology and Experimental Therapeutics.

[20]  R. Dantzer Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[21]  Shuxian Hu,et al.  Cytokine Expression in the Mouse Brain in Response to Immune Activation by Corynebacterium parvum , 2001, Clinical Diagnostic Laboratory Immunology.

[22]  C. Dinarello,et al.  The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. , 2000, Immunology today.

[23]  I. Goshen,et al.  Behavioral aspects of experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[24]  S. Rivest,et al.  How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli (44459) , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  M E Newman,et al.  Illness, Cytokines, and Depression , 2000, Annals of the New York Academy of Sciences.

[26]  J. G. Harrison,et al.  Pro-inflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes. , 1999, Journal of molecular and cellular cardiology.

[27]  M. Tsunoda,et al.  Effects of endotoxin and tumor necrosis factor α on regional brain neurotransmitters in mice , 1999 .

[28]  R. Blakely,et al.  Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. , 1999, Science.

[29]  K. Lesch,et al.  Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6 , 1998, Neurochemistry International.

[30]  Jiahuai Han,et al.  The p38 MAP kinase pathway and its biological function. , 1998, Trends in cardiovascular medicine.

[31]  R. Blakely,et al.  Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters* , 1998, The Journal of Biological Chemistry.

[32]  Kevin J. Tracey,et al.  Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia , 1997, Molecular medicine.

[33]  R. Spengler,et al.  Neuronal-associated tumor necrosis factor (TNFα): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration , 1997, Journal of Neuroimmunology.

[34]  J. Rapoport,et al.  Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. , 1997, Journal of immunology.

[35]  R. Blakely,et al.  Protein Kinase C Activation Regulates Human Serotonin Transporters in HEK-293 Cells via Altered Cell Surface Expression , 1997, The Journal of Neuroscience.

[36]  R. Dantzer,et al.  Mechanisms of sickness-induced decreases in food-motivated behavior , 1996, Neuroscience & Biobehavioral Reviews.

[37]  Scott R. Whittemore,et al.  Autocrine BDNF Secretion Enhances the Survival and Serotonergic Differentiation of Raphe Neuronal Precursor Cells Grafted into the Adult Rat CNS , 1996, Experimental Neurology.

[38]  V. Ganapathy,et al.  Regulation of the human serotonin transporter by interleukin-1 beta. , 1995, Biochemical and Biophysical Research Communications - BBRC.

[39]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[40]  R. Spengler,et al.  Tumor necrosis factor-α: presynaptic sensitivity is modified after antidepressant drug administration , 1994, Brain Research.

[41]  B. Hoffman,et al.  Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. , 1994, The Journal of biological chemistry.

[42]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor‐α‐like immunoreactivity in the murine central nervous system , 1993 .

[43]  A. Dunn Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. , 1992, The Journal of pharmacology and experimental therapeutics.

[44]  E. Wada,et al.  In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  G. Pasternak,et al.  Identification and characterization of receptors for tumor necrosis factor-α in the brain , 1991 .

[46]  G. Fillion,et al.  Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus , 1991, Neuroscience.

[47]  E. D. De Souza,et al.  Interleukin-1 receptors in mouse brain: characterization and neuronal localization. , 1990, Endocrinology.

[48]  H. Schoenfeld,et al.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[49]  H. Hohmann,et al.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). , 1989, The Journal of biological chemistry.

[50]  B. Aggarwal,et al.  Human tumor necrosis factor-alpha receptor. Purification by immunoaffinity chromatography and initial characterization. , 1988, The Journal of biological chemistry.

[51]  A. Morag,et al.  Post‐influenzal psychiatric disorder in adolescents , 1988, Acta psychiatrica Scandinavica.

[52]  C. March,et al.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. , 1988, Science.

[53]  C. Saper,et al.  Interleukin-1 immunoreactive innervation of the human hypothalamus. , 1988, Science.

[54]  C. Pert,et al.  Visualization and characterization of interleukin 1 receptors in brain. , 1987, Journal of immunology.

[55]  A. Siegel,et al.  Potentiating role of interleukin-1beta (IL-1beta) and IL-1beta type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat. , 2005, Brain research.

[56]  S. Hyman,et al.  Molecular Neuropharmacology: A Foundation for Clinical Neuroscience , 2001 .

[57]  A. Reichenberg,et al.  Cytokines, "depression due to a general medical condition," and antidepressant drugs. , 1999, Advances in experimental medicine and biology.

[58]  M. Tsunoda,et al.  Effects of endotoxin and tumor necrosis factor alpha on regional brain neurotransmitters in mice. , 1999, Natural toxins.

[59]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[60]  R. Blakely,et al.  Regulation of Antidepressant-Sensitive Serotonin Transporters , 1997 .

[61]  A. Smith,et al.  Behavioural effects of infectious mononucleosis. , 1996, Neuropsychobiology.

[62]  C. Saper,et al.  Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. , 1993, The Journal of comparative neurology.

[63]  D. Palazzolo,et al.  Interleukin-1 inhibits serotonin release from the hypothalamus in vitro. , 1992, Life sciences.

[64]  G. Fillion,et al.  Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. , 1991, Neuroscience.

[65]  G. Pasternak,et al.  Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. , 1991, Biochemical and biophysical research communications.